Cite
MLA Citation
A. Falcone et al.. “2150 Low rates of hospitalizations with TAS-102 in the European (EU) subregion of the Phase 3 RECOURSE trial in patients (pts) with metastatic colorectal cancer (mCRC).” European journal of cancer, vol. 51, n.d., pp. S383–. http://access.bl.uk/ark:/81055/vdc_100030628213.0x00001d